News
Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data ...
The oral formulation led to up to 12.2% weight loss over three months, a weaker outcome versus late-stage treatments from Eli ...
Viking? Royal Caribbean? Celebrity? What is Dan's favorite cruise line originally appeared on TravelHost. Everyone asks "what ...
Viking Holdings Ltd (NYSE: VIK) shares slipped despite strong Q2 results and positive analyst outlook. Pricing power and ...
Fair gates open at 10 a.m. and close at 10 p.m. weekdays and 11 p.m. weekends Friday, Aug. 22, through Monday, Sept. 1, Oregon State Fairgrounds, 2330 17th St. N.E. Salem; admission $3-$12, ages 5 and ...
4h
MarketBeat on MSNIs Viking's Growth Still Worth the Premium?
Viking (NYSE: VIK) stock is down approximately 3% after the cruise line’s second-quarter earnings report. The company ...
Shares in Viking Therapeutics have lost more than 40% of their value after it reported phase 2 results that showed that its ...
In a statement on Tuesday, Viking Therapeutics, Inc. (NASDAQ:VKTX) said that its phase 2 trial for VK2735 tablet saw a ...
Viking Therapeutics Inc (NASDAQ: VKTX) reported new clinical data for its oral obesity drug – sending shares sharply lower as ...
The Minnesota Vikings are facing national controversy over male cheerleaders as former player Jack Brewer voiced strong ...
John and Rosemary Kaasa handed over $22,000 (just over £16k) for what should have been an idyllic 15-day European river ...
Q2 2025 Earnings Call Transcript August 19, 2025 Viking Holdings Ltd reports earnings inline with expectations. Reported EPS is $0.99 EPS, expectations were $0.99. Operator: Good morning. My name is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results